In conclusion, our study shows that LINC02454 increases glioma cell TMZ sensitivity by maintaining chromatin interactions between the SORBS2 gene and a LINC02454 enhancer and at the same time can decrease TMZ sensitivity of glioma cells by promoting DDR1 expression. This evidence concerns the gene LINC02454 and central nervous system cancer.